Elanco Animal Health Inc financial data

Symbol
ELAN on NYSE
Industry
Pharmaceutical Preparations
Location
2500 Innovation Way, Greenfield, Indiana
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 294 % +33.3%
Quick Ratio 131 % +30.9%
Debt-to-equity 132 % +15.3%
Return On Equity -20.6 % -1218%
Return On Assets -8.89 % -1119%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 494M shares +0.34%
Common Stock, Shares, Outstanding 494M shares +0.33%
Entity Public Float 4.9B USD -47.3%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 494M shares +0.33%
Weighted Average Number of Shares Outstanding, Diluted 494M shares +0.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.49B USD +3.89%
Research and Development Expense 341M USD +6.56%
Costs and Expenses 5.74B USD +29.5%
Nonoperating Income (Expense) -54M USD +11.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.24B USD -1096%
Income Tax Expense (Benefit) 11M USD +22.2%
Net Income (Loss) Attributable to Parent -1.26B USD -1011%
Earnings Per Share, Basic -2.55 USD/shares -1009%
Earnings Per Share, Diluted -2.55 USD/shares -1009%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 416M USD +13.4%
Accounts Receivable, after Allowance for Credit Loss, Current 999M USD -0.1%
Inventory, Net 1.61B USD -4.68%
Assets, Current 4.01B USD +9.83%
Property, Plant and Equipment, Net 949M USD -5.76%
Operating Lease, Right-of-Use Asset 140M USD -0.71%
Intangible Assets, Net (Excluding Goodwill) 4B USD -14.5%
Goodwill 4.48B USD -25.8%
Other Assets, Noncurrent 324M USD -22.7%
Assets 13.8B USD -12.9%
Accounts Payable, Current 291M USD -17.8%
Employee-related Liabilities, Current 157M USD +7.53%
Contract with Customer, Liability, Current 356M USD +7.23%
Liabilities, Current 1.37B USD +6.7%
Deferred Income Tax Liabilities, Net 524M USD -20.4%
Operating Lease, Liability, Noncurrent 110M USD -0.9%
Other Liabilities, Noncurrent 465M USD +13.1%
Liabilities 7.82B USD -6.61%
Accumulated Other Comprehensive Income (Loss), Net of Tax -542M USD -92.9%
Retained Earnings (Accumulated Deficit) -2.31B USD -119%
Stockholders' Equity Attributable to Parent 5.94B USD -19.9%
Liabilities and Equity 13.8B USD -12.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2M USD
Net Cash Provided by (Used in) Financing Activities -27M USD -116%
Net Cash Provided by (Used in) Investing Activities 37M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 494M shares +0.33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7M USD +74.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 416M USD +13.4%
Deferred Tax Assets, Valuation Allowance 363M USD +59.2%
Deferred Tax Assets, Gross 815M USD +13.2%
Operating Lease, Liability 142M USD 0%
Payments to Acquire Property, Plant, and Equipment 24M USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.52B USD -695%
Lessee, Operating Lease, Liability, to be Paid 164M USD 0%
Property, Plant and Equipment, Gross 1.84B USD +6.91%
Operating Lease, Liability, Current 32M USD +3.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 30M USD +7.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 39M USD +8.33%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) 2M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25M USD +13.6%
Deferred Tax Assets, Operating Loss Carryforwards 314M USD -4.56%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 31M USD +93.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16M USD -5.88%
Additional Paid in Capital 8.79B USD +0.43%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 542M USD +2.65%
Depreciation, Depletion and Amortization 166M USD -4.05%
Deferred Tax Assets, Net of Valuation Allowance 452M USD -8.13%
Interest Expense 270M USD +3.85%